Back to search results

CONTIGO: Video Intervention for Hereditary Breast and Ovarian Cancer in Latina Women

This study, called CONTIGO, is looking at ways to help Latina women at risk for hereditary breast and ovarian cancer (HBOC) learn more about genetic counseling and testing. Researchers are comparing two approaches: a culturally targeted video called "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor" and a fact sheet from FORCE (Facing Our Risk of Cancer Empowered). You would be randomly assigned to receive either the video or the fact sheet. The main goal is to see if these tools encourage more women to get genetic counseling and testing. This study is for Latina women aged 18 or older who speak Spanish, meet specific criteria for HBOC risk, and have not had genetic counseling or testing before.

Study design
This is a randomized controlled trial aiming to enroll 332 women. Participants will be randomly assigned to one of two groups: watching a video or receiving a fact sheet.
What's involved
Participants will watch a video or read a fact sheet. Genetic counseling and testing uptake will be measured four months after the baseline survey.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for four months after the baseline survey to measure genetic counseling and testing uptake.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05130606

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

Recruiting
NAAges 18+InterventionalPrevention
Georgetown University
~332 participants
Updated 2025-08-28 on ClinicalTrials.gov
What's tested:Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor."FORCE Fact Sheet

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Uptake of Genetic Counseling
Measured over Change from the baseline survey to four months after baseline
+1 more outcome measured

Conditions

Hereditary Breast and Ovarian Cancer

Explore related trials

BRCA1/2-Associated Hereditary Breast and Ovarian Cancer SyndromeBreast CarcinomaMalignant Ovarian Neoplasm

Where it's being run

2 sites across 2 states
District of Columbia1
Virginia1

Study leadership

  • Alejandra Hurtado de Mendoza, Ph.D · PRINCIPAL_INVESTIGATOR · Georgetown Lombardi Comprehensive Cancer Center

Who to contact

Alejandra Hurtado de Mendoza, Ph.D
[email protected]
2026878916
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Self-identify as a Latina woman
Be 18 years old or older
Be able to provide informed consent
Be fluent in Spanish
Meet NCCN criteria to be considered for genetic cancer risk assessment for HBOC, whether by a personal history of cancer or family history of cancer
No previous participation in genetic counseling or testing for hereditary breast and ovarian cancer risk
No other family members are participating in this study
Have not participated in any previous studies involving interventions about HBOC or GCT
Be 18 years old or older
Be fluent in English or Spanish
Have a role in the partner community clinic as either a) full-time or part-time employee b) intern c) volunteer

What this trial measures

  • Uptake of Genetic CounselingChange from the baseline survey to four months after baseline

    Participants will self report whether they attended a genetic counseling session in the four months following their baseline survey. The study team will also have direct access to the genetic counseling company's records.

  • Uptake of Genetic TestingChange from the baseline survey to four months after baseline

    Participants will self report whether they completed a genetic test for hereditary cancer in the four months following their baseline survey. The study team will also have direct access to the genetic counseling company's records.